Umbrella Labs Announces GLP-3R, The New Research Designation For Retatrutide, To Support High Rigor Tri-Receptor Endocrine Signaling Bench Science TUCSON, AZ / ACCESS Newswire / February 26, 2026 / Umbrella Labs today announced an updated research catalog standard that formally presents GLP-3R as the internal research designation for retatrutide, also identified as LY-3437943, supplied as a lyophilized peptide vial for laboratory developmental research use only
and its partners do not accept liability for misuse, adverse effects, or consequences resulting from the use of any product or information provided
Shay, Marc S
If BPC-157 is the modern peptide prodigy, Methylene Blue is the seasoned veteran with a history stretching back to the 19th century
Identification of CB-27 as a Novel Antiplasmodial Compound Targeting P
Its not a substitute for professional medical advice, diagnosis, or treatment